KATELYN ROGERS: Open Payments
NPI 1053877761 · JOHNSONVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,006 in 54 payments from 10 companies in 2025. Trend: 2023 $1,524 · 2024 $1,286 · 2025 $1,006
Food & beverage: $1,006
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $283 |
| AstraZeneca Pharmaceuticals LP | 8 | $246 |
| GENZYME CORPORATION | 5 | $164 |
| Novo Nordisk Inc | 6 | $138 |
| Amgen Inc. | 4 | $70 |
| GlaxoSmithKline, LLC. | 2 | $32 |
| Lilly USA, LLC | 1 | $22 |
| Exact Sciences Corporation | 1 | $21 |
| PFIZER INC. | 1 | $16 |
| TOLMAR, INC. | 1 | $15 |
Products named: VRAYLAR, DUPIXENT, AIRSUPRA, Ozempic, OTEZLA, RINVOQ, FARXIGA, CREON.
Industry payments across SC — which companies pay providers there.
